Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
LTRN - Lantern Pharma Inc - Stock Price Chart
TickerLTRN [NASD]
CompanyLantern Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap39.93MEPS (ttm)-1.84
P/E-EPS this Y4.66%
Forward P/E-EPS next Y-6.52%
PEG-EPS past 5Y-37.87%
P/S-EPS next 5Y-2.53%
P/B2.38EPS Q/Q16.94%
Dividend-Sales Q/Q-
Insider Own24.31%Inst Own11.37%
Insider Trans-10.75%Inst Trans-15.29%
Short Float3.21%EarningsMay 15/b
Analyst Recom1.00Target Price25.00
Avg Volume130.50K52W Range2.55 - 6.12
Today 09:40AM Lantern Pharma Unveils Groundbreaking AI-Powered Module to Predict Activity and Efficacy of Combination Regimens in Clinical Cancer Treatment (Business Wire) -7.20%
Jun-16-25 08:30AM Lung Cancer Patient in Lantern Pharma's Harmonic Trial Shows Durable Complete Response in Target Cancer Lesions with Survival Continuing for Nearly Two Years (Business Wire)
May-29-25 11:21PM Lantern Pharma Inc. (LTRN)'s LP-184 Shows 345% Survival Gain in Rare Pediatric Brain Tumor Models (Insider Monkey) +9.06%
08:30AM Lantern Pharma's LP-184 Shows Promising In Vivo Activity in Atypical Teratoid Rhabdoid Tumors (ATRT) at SNO Pediatric Conference, Further Validating Rare Pediatric Disease Designation and Pathway to Clinical Trials (Business Wire)
May-15-25 08:45AM Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates (Business Wire)
May-12-25 09:00AM Lantern Pharma Secures FDA Clearance for Planned Phase 1b/2 Trial of LP-184 in Biomarker-Defined, Treatment-Resistant NSCLC Patients with High Unmet Clinical Need (Business Wire)
08:31AM EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients (Benzinga)
May-08-25 08:30AM Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET (Business Wire) -11.06%
May-05-25 08:55AM Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC) (Business Wire)
08:31AM EXCLUSIVE: Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial (Benzinga)
ANGO - Angiodynamic Inc - Stock Price Chart
TickerANGO [NASD, RUT]
CompanyAngiodynamic Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap362.02MEPS (ttm)-1.02
P/E-EPS this Y-30.53%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.28EPS next 5Y-
P/B1.97EPS Q/Q97.69%
Dividend-Sales Q/Q-4.23%
Insider Own4.63%Inst Own89.76%
Insider Trans-0.22%Inst Trans11.40%
Short Float6.47%EarningsJul 15/b
Analyst Recom1.00Target Price15.00
Avg Volume514.24K52W Range5.82 - 13.50
CRML - Critical Metals Corp - Stock Price Chart
TickerCRML [NASD, RUT]
CompanyCritical Metals Corp
CountryUnited Kingdom
IndustryOther Industrial Metals & Mining
Market Cap350.76MEPS (ttm)-1.96
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-1061.66%
P/S-EPS next 5Y-
P/B4.32EPS Q/Q-493.10%
Dividend-Sales Q/Q-
Insider Own78.38%Inst Own6.95%
Insider Trans0.00%Inst Trans11.39%
Short Float11.33%Earnings-
Analyst Recom-Target Price-
Avg Volume4.25M52W Range1.23 - 11.13
JDZG - Jiade Ltd - Stock Price Chart
TickerJDZG [NASD]
CompanyJiade Ltd
CountryChina
IndustryInformation Technology Services
Market Cap8.29MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own74.18%Inst Own0.15%
Insider Trans0.00%Inst Trans-
Short Float1.96%Earnings-
Analyst Recom-Target Price-
Avg Volume65.05K52W Range1.61 - 21.28
JFB - JFB Construction Holdings - Stock Price Chart
TickerJFB [NASD]
CompanyJFB Construction Holdings
CountryUSA
IndustryReal Estate - Development
Market Cap73.07MEPS (ttm)0.00
P/E1949.38EPS this Y-97.20%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2.82EPS next 5Y-
P/B6.55EPS Q/Q-73.30%
Dividend-Sales Q/Q90.30%
Insider Own79.50%Inst Own0.60%
Insider Trans2.67%Inst Trans0.05%
Short Float1.68%Earnings-
Analyst Recom-Target Price-
Avg Volume31.65K52W Range3.39 - 10.46
INKT - MiNK Therapeutics Inc - Stock Price Chart
TickerINKT [NASD]
CompanyMiNK Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap114.63MEPS (ttm)-2.50
P/E-EPS this Y30.94%
Forward P/E-EPS next Y6.58%
PEG-EPS past 5Y16.86%
P/S-EPS next 5Y15.43%
P/B-EPS Q/Q36.60%
Dividend-Sales Q/Q-
Insider Own75.14%Inst Own1.58%
Insider Trans0.00%Inst Trans-21.92%
Short Float1.30%EarningsMay 15/b
Analyst Recom2.00Target Price35.00
Avg Volume874.75K52W Range4.56 - 76.00
Jul-14-25Downgrade William Blair Outperform → Mkt Perform
SMX - SMX (Security Matters) Plc - Stock Price Chart
TickerSMX [NASD]
CompanySMX (Security Matters) Plc
CountryIreland
IndustrySpecialty Business Services
Market Cap4.21MEPS (ttm)-3394.84
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.07EPS Q/Q-64761.20%
Dividend-Sales Q/Q-
Insider Own0.05%Inst Own0.29%
Insider Trans0.00%Inst Trans-
Short Float1.68%Earnings-
Analyst Recom-Target Price-
Avg Volume231.36K52W Range1.68 - 851.84
OCC - Optical Cable Corp - Stock Price Chart
TickerOCC [NASD]
CompanyOptical Cable Corp
CountryUSA
IndustryCommunication Equipment
Market Cap46.92MEPS (ttm)-0.38
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y6.68%
P/S0.68EPS next 5Y-
P/B2.44EPS Q/Q56.91%
Dividend-Sales Q/Q8.92%
Insider Own30.54%Inst Own16.14%
Insider Trans0.00%Inst Trans11.38%
Short Float0.08%EarningsJun 05/b
Analyst Recom-Target Price-
Avg Volume249.07K52W Range2.02 - 7.00
BWEN - Broadwind Inc - Stock Price Chart
TickerBWEN [NASD]
CompanyBroadwind Inc
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap49.91MEPS (ttm)-0.03
P/E-EPS this Y53.33%
Forward P/E13.20EPS next Y117.39%
PEG-EPS past 5Y-
P/S0.35EPS next 5Y-
P/B0.85EPS Q/Q-123.99%
Dividend-Sales Q/Q-2.07%
Insider Own13.73%Inst Own25.36%
Insider Trans-0.10%Inst Trans8.83%
Short Float0.89%EarningsMay 13/b
Analyst Recom1.00Target Price4.33
Avg Volume103.35K52W Range1.41 - 3.69
BSGM - Biosig Technologies Inc - Stock Price Chart
TickerBSGM [NASD]
CompanyBiosig Technologies Inc
CountryUSA
IndustryMedical Devices
Market Cap146.11MEPS (ttm)-0.62
P/E-EPS this Y66.67%
Forward P/E-EPS next Y32.00%
PEG-EPS past 5Y46.11%
P/S4870.43EPS next 5Y-
P/B44.17EPS Q/Q62.27%
Dividend-Sales Q/Q-100.00%
Insider Own39.71%Inst Own24.53%
Insider Trans0.00%Inst Trans7.91%
Short Float7.27%EarningsMay 19
Analyst Recom1.00Target Price10.00
Avg Volume1.07M52W Range0.23 - 14.11
Jul-14-25 08:30AM BSGM Engages CXG to Acquire FINRA/SEC-Registered Broker-Dealer to Expand Publicly Traded RWA Tokenization Operations (Business Wire)
10:06AM CORRECTION: BioSig & Streamex Clarify and Correct Details of Russell Starrs Appointment and Biography (Business Wire)
Jul-11-25 09:00AM BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor (Business Wire) -10.75%
Jul-08-25 12:29PM BioSig, Streamex to Raise $1.1B for Gold Tokenization Initiative on Solana (CoinDesk) -27.36%
Jul-07-25 06:41PM BioSig Technologies, Inc. and Streamex Exchange Corporation Announce Definitive Agreements for up to $1.1B USD in Growth Financing to Launch Gold Backed Treasury Management Strategy and to Rapidly Expand RWA Tokenization for the Commodities Markets (Business Wire) +10.95%
Jun-09-25 10:30AM BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors (GlobeNewswire) -14.05%
Jun-04-25 08:25AM BioSig & Streamex Appoint Co-Founder of the Osisko Group & Mining Visionary, Sean Roosen as Strategic Advisor (GlobeNewswire) -10.59%
May-28-25 06:45PM CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO) (GlobeNewswire) -8.74% -13.68%
01:46PM BioSig Appoints Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (GlobeNewswire)
01:07PM Streamex and BioSig Announce the Successful Closing of Share Exchange Transaction and Executive Leadership Changes Bringing a First-Mover Real World Asset Tokenization Company to the Nasdaq (GlobeNewswire)
1234567891020